TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SARomics Biostructures AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
28,701
|
26,585
|
22,893 |
Financial expenses |
19
|
563
|
86 |
Earnings before taxes |
939
|
2,713
|
1,693 |
EBITDA |
1,188
|
3,391
|
2,447 |
Total assets |
15,642
|
15,625
|
14,060 |
Current assets |
10,862
|
11,459
|
9,564 |
Current liabilities |
6,323
|
6,951
|
7,392 |
Equity capital |
8,796
|
8,077
|
6,051 |
- share capital |
136
![]() |
136
![]() |
136 |
Employees (average) |
27
|
22
|
20 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.2%
|
51.7%
|
43.0% |
Turnover per employee |
1,063
|
1,208
|
1,145 |
Profit as a percentage of turnover |
3.3%
|
10.2%
|
7.4% |
Return on assets (ROA) |
6.1%
|
21.0%
|
12.7% |
Current ratio |
171.8%
|
164.9%
|
129.4% |
Return on equity (ROE) |
10.7%
|
33.6%
|
28.0% |
Change turnover |
2,116
|
3,692
|
3,800 |
Change turnover % |
8%
|
16%
|
20% |
Chg. No. of employees |
5
|
2
![]() |
2 |
Chg. No. of employees % |
23%
|
10%
|
11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.